Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Account Payables (2016 - 2026)

Collegium Pharmaceutical has reported Change in Account Payables over the past 10 years, most recently at $3.0 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 275.93% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $6.7 million, up 159.57%, while the annual FY2025 figure was $6.7 million, 159.57% up from the prior year.
  • Change in Account Payables for Q4 2025 was $3.0 million at Collegium Pharmaceutical, up from -$3.3 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $13.9 million in Q1 2025 and troughed at -$7.0 million in Q2 2025.
  • A 5-year average of -$301650.0 and a median of -$537500.0 in 2023 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: tumbled 1150.0% in 2021 and later soared 648.86% in 2025.
  • Year by year, Change in Account Payables stood at -$3.5 million in 2021, then dropped by 17.0% to -$4.1 million in 2022, then soared by 219.6% to $5.0 million in 2023, then crashed by 83.65% to $810000.0 in 2024, then skyrocketed by 275.93% to $3.0 million in 2025.
  • Business Quant data shows Change in Account Payables for COLL at $3.0 million in Q4 2025, -$3.3 million in Q3 2025, and -$7.0 million in Q2 2025.